Cargando…
Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study
Diencephalic syndrome (DS) is a rare pediatric condition associated with optic pathway gliomas (OPGs). Since they are slow-growing tumors, their diagnosis might be delayed, with consequences on long-term outcomes. We present a multicenter case series of nine children with DS associated with OPG, wit...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947184/ https://www.ncbi.nlm.nih.gov/pubmed/35328218 http://dx.doi.org/10.3390/diagnostics12030664 |
_version_ | 1784674378686922752 |
---|---|
author | De Martino, Lucia Picariello, Stefania Triarico, Silvia Improda, Nicola Spennato, Pietro Capozza, Michele Antonio Grandone, Anna Santoro, Claudia Cioffi, Daniela Attinà, Giorgio Cinalli, Giuseppe Ruggiero, Antonio Quaglietta, Lucia |
author_facet | De Martino, Lucia Picariello, Stefania Triarico, Silvia Improda, Nicola Spennato, Pietro Capozza, Michele Antonio Grandone, Anna Santoro, Claudia Cioffi, Daniela Attinà, Giorgio Cinalli, Giuseppe Ruggiero, Antonio Quaglietta, Lucia |
author_sort | De Martino, Lucia |
collection | PubMed |
description | Diencephalic syndrome (DS) is a rare pediatric condition associated with optic pathway gliomas (OPGs). Since they are slow-growing tumors, their diagnosis might be delayed, with consequences on long-term outcomes. We present a multicenter case series of nine children with DS associated with OPG, with the aim of providing relevant details about mortality and long-term sequelae. We retrospectively identified nine children (6 M) with DS (median age 14 months, range 3–26 months). Four patients had NF1-related OPGs. Children with NF1 were significantly older than sporadic cases (median (range) age in months: 21.2 (14–26) versus 10 (3–17); p = 0.015). Seven tumors were histologically confirmed as low-grade astrocytomas. All patients received upfront chemotherapy and nutritional support. Although no patient died, all of them experienced tumor progression within 5.67 years since diagnosis and were treated with several lines of chemotherapy and/or surgery. Long-term sequelae included visual, pituitary and neurological dysfunction. Despite an excellent overall survival, PFS rates are poor in OPGs with DS. These patients invariably present visual, neurological or endocrine sequelae. Therefore, functional outcomes and quality-of-life measures should be considered in prospective trials involving patients with OPGs, aiming to identify “high-risk” patients and to better individualize treatment. |
format | Online Article Text |
id | pubmed-8947184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89471842022-03-25 Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study De Martino, Lucia Picariello, Stefania Triarico, Silvia Improda, Nicola Spennato, Pietro Capozza, Michele Antonio Grandone, Anna Santoro, Claudia Cioffi, Daniela Attinà, Giorgio Cinalli, Giuseppe Ruggiero, Antonio Quaglietta, Lucia Diagnostics (Basel) Article Diencephalic syndrome (DS) is a rare pediatric condition associated with optic pathway gliomas (OPGs). Since they are slow-growing tumors, their diagnosis might be delayed, with consequences on long-term outcomes. We present a multicenter case series of nine children with DS associated with OPG, with the aim of providing relevant details about mortality and long-term sequelae. We retrospectively identified nine children (6 M) with DS (median age 14 months, range 3–26 months). Four patients had NF1-related OPGs. Children with NF1 were significantly older than sporadic cases (median (range) age in months: 21.2 (14–26) versus 10 (3–17); p = 0.015). Seven tumors were histologically confirmed as low-grade astrocytomas. All patients received upfront chemotherapy and nutritional support. Although no patient died, all of them experienced tumor progression within 5.67 years since diagnosis and were treated with several lines of chemotherapy and/or surgery. Long-term sequelae included visual, pituitary and neurological dysfunction. Despite an excellent overall survival, PFS rates are poor in OPGs with DS. These patients invariably present visual, neurological or endocrine sequelae. Therefore, functional outcomes and quality-of-life measures should be considered in prospective trials involving patients with OPGs, aiming to identify “high-risk” patients and to better individualize treatment. MDPI 2022-03-09 /pmc/articles/PMC8947184/ /pubmed/35328218 http://dx.doi.org/10.3390/diagnostics12030664 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article De Martino, Lucia Picariello, Stefania Triarico, Silvia Improda, Nicola Spennato, Pietro Capozza, Michele Antonio Grandone, Anna Santoro, Claudia Cioffi, Daniela Attinà, Giorgio Cinalli, Giuseppe Ruggiero, Antonio Quaglietta, Lucia Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study |
title | Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study |
title_full | Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study |
title_fullStr | Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study |
title_full_unstemmed | Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study |
title_short | Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study |
title_sort | diencephalic syndrome due to optic pathway gliomas in pediatric patients: an italian multicenter study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947184/ https://www.ncbi.nlm.nih.gov/pubmed/35328218 http://dx.doi.org/10.3390/diagnostics12030664 |
work_keys_str_mv | AT demartinolucia diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT picariellostefania diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT triaricosilvia diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT improdanicola diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT spennatopietro diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT capozzamicheleantonio diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT grandoneanna diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT santoroclaudia diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT cioffidaniela diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT attinagiorgio diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT cinalligiuseppe diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT ruggieroantonio diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy AT quagliettalucia diencephalicsyndromeduetoopticpathwaygliomasinpediatricpatientsanitalianmulticenterstudy |